The Breast Reconstruction Market report offers a comprehensive valuation of the market place. It commits different factors affecting Breast Reconstruction industry such as market environment, various policies of the government, past data and market trends, technological advancements, upcoming innovations, market risk factors, market restraints, and challenges in the industry.
Global Breast Reconstruction Market is expected to rise from its initial estimated value of USD 541.68 million in 2018 to an estimated value of USD 726.62 million by 2026, registering a CAGR of 3.74% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence and adoption of breast reconstruction procedures globally for aesthetic purposes.
To Get The Sample Of The Report Click On: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-reconstruction-market
Market Definition: Global Breast Reconstruction Market
Breast reconstruction is the process of restoring the shape and size of breasts generally conducted in women. This process involves reconstructing or reshaping the breasts usually after mastectomy or lumpectomy. This process is different from breast cancer surgery although it can be conducted immediately afterwards or after a certain time period depending on the need of the patient. The implants used in reconstructive surgeries are combined with a tissue extracted from the patient’s body itself, they do not include the nipple, although the patients can choose to have it surgically created or created with the help of tattoos, even prosthetic stick-on options are available.
Key Market Competitors:
Few of the major competitors currently working in the breast reconstruction market are Mentor Worldwide LLC; GROUPE SEBBIN SAS; Establishment Labs S.A.; ALLERGAN; Sientra, Inc.; POLYTECH Health & Aesthetics GmbH; Guangzhou Wanhe Plastic Materials Co., Ltd.; GC Aesthetics; IDEAL IMPLANT INCORPORATED; HANSBIOMED CO., LTD; RTI Surgical Holdings, Inc.; Integra LifeSciences; CEREPLAS; Shanghai Kangning Medical Supplies Ltd.; Silimed; AirXpanders, Inc.; TapMed Medizintechnik Handels GmbH and laboratoires arion.
- Rise in prevalence of breast cancer globally is expected to positively affect the growth of the market
- Rising awareness regarding the technology of breast reconstruction, products; innovative product launches provided by the major healthcare manufacturers are expected to positively drive the growth of the market
- High prevalence and cases of complications with breast implants after reconstructive surgeries are expected to restrain the growth of the market
- High cost of the products and surgical procedures are expected to restrain the growth of the market
Speak to Research Analyst for Regional Customization or Other Query: https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-breast-reconstruction-market
Segmentation: Global Breast Reconstruction Market
- Breast Implants
- Silicone Implants
- Saline Implants
- Tissue Expanders
- Implants Accessories
- Acellular Dermal Matrix (ADM)
By Reconstruction Shape
- Round Implant Shape
- Anatomical Implant Shape
- Round Expander Shape
- Anatomical Expander Shape
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
- Ambulatory Surgical Centers
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East & Africa
Key Developments in the Market:
- In October 2018, Mentor Worldwide LLC announced the launch of a tissue expander to its “CPX4 Breast Tissue Expanders” series available in the United States. The new CPX4 smooth expander is designed specifically to increase the comfort levels of patients and helping physicians offer better ease during prepectoral and submuscular breast reconstruction.
- In September 2017, AirXpanders, Inc. announced that they are transferring their manufacturing responsibilities to a Costa Rican contract manufacturing organization, MedPlast for their “AeroForm Tissue Expander System”. This will enable them to increase the capacity of manufacturing by 20,000 units annually. The existing manufacturing unit of AirXpanders, Inc. will continue to operate and provide 4,000 units annually in California, United States.
- In February 2017, ALLERGAN announced that they had completed the acquisition of LifeCell Corporation for an approximate amount of USD 2.9 billion. This acquisition will help them in expanding their product portfolio and service offerings of aesthetics and plastic surgery business divisions.
Global breast reconstruction market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of breast reconstruction market for Global, Europe, North America, Asia-Pacific, South America, Middle East & Africa.
Want Full Report? Visit Here For Enquiry: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-breast-reconstruction-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing email@example.com . We are content with our glorious 99.9 % client satisfying rate.